ULBI · NASDAQ
Ultralife (ULBI) Stock Price & Fundamentals
Ultralife (ULBI) closed at $360.40 on Oct 9, 2026, up 0.57% from the previous close of $358.35.
Share price, past year
1Y +3.20%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $360.40 |
| Sep 30, 2026 | $352.08 |
| Aug 31, 2026 | $353.50 |
| Jul 31, 2026 | $377.17 |
| Jun 30, 2026 | $390.93 |
| May 29, 2026 | $407.16 |
| Apr 30, 2026 | $412.34 |
| Mar 31, 2026 | $415.65 |
| Feb 27, 2026 | $387.73 |
| Jan 30, 2026 | $366.23 |
| Dec 31, 2025 | $364.94 |
| Nov 28, 2025 | $360.89 |
| Oct 31, 2025 | $361.13 |
Key statistics
- Market cap
- $6.01B
- P/E (TTM)
- —
- EPS (TTM)
- −$39.00
- Revenue (TTM)
- $187.24M
- Net income (TTM)
- −$6.55M
- Shares outstanding
- 16.7M
- Dividend yield
- —
- 52-week range
- $344.23 – $429.32
Ultralife's market cap is $6.01B, based on a share price of $360.40 and 16.7M shares outstanding as of Jun 30, 2026.
Financials
Ultralife reported revenue of $191.16M for fiscal 2025, up 16.24% from fiscal 2024.
Ultralife reported a net loss of $5.90M in fiscal 2025.
Fiscal 2025 revenue was the highest in the 10 years shown.
Ultralife's fiscal 2025 net loss was its first in at least 3 years.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $191.16M | +16.2% | −$5.90M | −3.1% | −$35.00 | $7.12M |
| FY2024ended Dec 31, 2024 | $164.46M | +3.7% | $6.31M | 3.8% | $38.00 | $14.70M |
| FY2023ended Dec 31, 2023 | $158.64M | +20.3% | $7.20M | 4.5% | $0.44 | −$623.00K |
| FY2022ended Dec 31, 2022 | $131.84M | +34.2% | −$119.00K | −0.1% | $0.05 | −$2.94M |
| FY2021ended Dec 31, 2021 | $98.27M | −8.8% | −$234.00K | −0.2% | $0.05 | $1.51M |
| FY2020ended Dec 31, 2020 | $107.71M | +0.9% | $5.23M | 4.9% | $0.33 | $18.62M |
| FY2019ended Dec 31, 2019 | $106.80M | +22.5% | $5.21M | 4.9% | $32.00 | −$9.25M |
| FY2018ended Dec 31, 2018 | $87.19M | +1.9% | $24.93M | 28.6% | $1.53 | $6.70M |
| FY2017ended Dec 31, 2017 | $85.53M | +3.7% | $7.65M | 8.9% | $0.48 | $5.88M |
| FY2016ended Dec 31, 2016 | $82.46M | — | $3.51M | 4.3% | $0.23 | $6.43M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $47.94M | $2.54M | $15.00 |
| Q1 FY2026ended Mar 31, 2026 | $47.45M | −$451.00K | −$3.00 |
| Q4 FY2025ended Dec 31, 2025 | $48.48M | −$7.42M | −$50.93 |
| Q3 FY2025ended Sep 30, 2025 | $43.37M | −$1.22M | −$0.07 |
| Q2 FY2025ended Jun 30, 2025 | $48.56M | $879.00K | $5.00 |
| Q1 FY2025ended Mar 31, 2025 | $50.75M | $1.87M | $11.00 |
| Q4 FY2024ended Dec 31, 2024 | $43.85M | $194.00K | $37.72 |
| Q3 FY2024ended Sep 30, 2024 | $35.69M | $258.00K | $0.02 |
Company profile
- Name
- Ultralife Corporation
- Ticker
- ULBI
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Miscellaneous Electrical Machinery, Equipment & Supplies
- Headquarters
- 2000 Technology Parkway, Newark, NY 14513
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0000875657
Recent SEC filings
- Aug 7, 2026
- Aug 7, 2026
- Jul 23, 2026
- May 8, 2026
- May 8, 2026
- Apr 29, 2026
- Mar 23, 2026
- Mar 10, 2026
Frequently asked questions
What is Ultralife's stock price?
Ultralife (ULBI) closed at $360.40 on Oct 9, 2026, up 0.57% from the previous close of $358.35.
What is Ultralife's market cap?
Ultralife's market cap is $6.01B, based on a share price of $360.40 and 16.7M shares outstanding as of Jun 30, 2026.
How much revenue does Ultralife make?
Ultralife reported revenue of $191.16M for fiscal 2025, up 16.24% from fiscal 2024.
Does Ultralife pay a dividend?
Ultralife's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Ultralife Corporation's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures